Navigation Links
Aflac Incorporated To Release First Quarter Results on April 23, 2008
Date:4/16/2008

COLUMBUS, Ga., April 16 /PRNewswire-FirstCall/ -- Aflac Incorporated (NYSE: AFL) announced today that it will release first quarter financial results after the market closes on April 23, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20041202/CLTH019LOGO )

In conjunction with the earnings release, Aflac Incorporated will webcast a conference call scheduled for 9:00 a.m. (EDT) on April 24, 2007. During the teleconference, Aflac Incorporated Chairman and CEO Dan Amos will discuss first quarter results and the outlook for 2008. Other Aflac executives will be available to answer questions, including Aflac Incorporated President and CFO Kriss Cloninger; President and COO of Aflac Japan Tohru Tonoike; President of Aflac and COO of Aflac U.S. Paul Amos II; and Senior Vice President and CIO Jerry Jeffery.

To listen to the first quarter conference call webcast, visit aflac.com and click on the Investors page. Registration is required, so please allow five to seven minutes to sign up prior to the scheduled start time.

For more than 50 years, Aflac products have given policyholders the opportunity to direct cash where it is needed most when a life-interrupting medical event causes financial challenges. Aflac is the number one provider of guaranteed-renewable insurance in the United States and the number one insurance company in terms of individual insurance policies in force in Japan. Our insurance products provide protection to more than 40 million people worldwide. Aflac has been included in Fortune magazine's listing of America's Most Admired Companies for seven years and in Fortune magazine's list of the 100 Best Companies to Work Fo
'/>"/>

SOURCE Aflac Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Aflac Announces Resignation of U.S. Marketing Officer
2. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
3. Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
4. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
5. Aflac Japan To Offer Cancer Insurance Product Through Japan Post
6. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
7. Aflac to Sponsor Iron Girl
8. Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
9. Aflac Incorporated Announces Fourth Quarter Results
10. Training Magazine Applauds Aflacs Employee Learning Programs
11. Aflac Incorporated to Present at the Raymond James 29th Annual Institutional Investors Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...a statement of concern issued by a senior health o...ing the financial and human resources // needed ...roblem is more severe in southern and western regi...l it," Mr Wu a top Aids official at the Chinese Ce...
...ombination of radiation and gold nanoparticles can...disease, according to a research conducted by scie.../ cells will not be affected by this. According t...emical Society's Nano Letters, the technique, a ty...
...ts pharmacies have handed out over 6,000 chlamydia...a pilot scheme aimed at tackling the silent sex di...Screening Program which last year revealed as many... have the disease. The trial was launched in Novem...
...S strategies designed to detect and contain the sp...ch more needs to be done than mere rhetoric // on...from spreading beyond the recognized risk groups o...ere that testing for AIDS assumes massive importan...
Other Medicine News:Health News:Need of the Hour: Viable Strategies against AIDS 2
(Date:9/4/2008)... MELBOURNE, Australia, Sept. 4 /- C...is commencing enrolment for its Phase Ib/II,study ... anticancer agent,in patients with an aggressive ...rme (GBM)., The GBM clinical trial is the first P...umor indications for the company and the second in...
(Date:9/4/2008)... Practice Bulletin for Obstetrician-Gynecologist...ractice Change-Minimally Invasive Interventional,R...omen With Uterine,Fibroids, FAIRFAX, Va., Sept. 4...ntional Radiology, a national organization of near...fessionals dedicated to improving health,care thro...
(Date:9/4/2008)... 100 mg cohort demonstrates potent antiviral activ... profile -, CAMBRIDGE, Mass., Sept. 4 /PRNews...asdaq: IDIX ), a biopharmaceutical company engage...e treatment of human viral,and other infectious di...proof-of-concept study evaluating IDX899, a non-nu...
(Date:9/3/2008)... NANJING, China, Sept. 3 /PRNewswire-FirstCall/ ...eading manufacturer and supplier of,branded generi...,anti-cancer biotech product Endu (also known as E...f Endu Phase IV clinical study., At the request o...study,to further validate the safety and therapeut...
Breaking Medicine Technology:Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Pelosi Statement on House Passage of Global AIDS Legislation 24381 1Pelosi Statement on House Passage of Global AIDS Legislation 24381 2NuVasive Completes Acquisition of Osteocel Biologics Business 6732 1NuVasive Completes Acquisition of Osteocel Biologics Business 6732 2NuVasive Completes Acquisition of Osteocel Biologics Business 6732 3NuVasive Completes Acquisition of Osteocel Biologics Business 6732 4NuVasive Completes Acquisition of Osteocel Biologics Business 6732 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 1Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009 6730 8Rochester Medical Announces Third Quarter 2008 Earnings Conference Call July 31 2008 6727 1Rochester Medical Announces Third Quarter 2008 Earnings Conference Call July 31 2008 6727 2
Clearview C. Diff A is a one-step test for the direct qualitative detection of Clostridium difficile toxin A from fecal samples.
ThyroTest TSH is a rapid, qualitative test for hypothyroidism screening in adults.
...est is one of the easiest tests to run on the mark...s with no hands-on time. Critical care instruction...aving the pediatrician's office and valuable infor... to help control the spread of RSV infections. Now...
The BinaxNOW Influenza A & B Test simplifies rapid influenza testing. The easiest flu test on the market just got easier with accurate differentiation between influenza A and influenza B using one si
Medicine Products: